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A commentary on 
Memory CD8+ T cells colocalize with IL-7+ stromal cells in bone marrow and rest in terms of 
proliferation and transcription
by Sercan Alp O, Durlanik S, Schulz D, McGrath M, Grun JR, Bardua M, et al. Eur J Immunol (2015) 
45:975–87. doi: 10.1002/eji.201445295
Several studies have shown that the bone marrow (BM) is implicated in the long-lasting persistence 
of memory CD8 T cells [see Ref. (1) and references therein]. Generally, it has been thought that 
the BM accomplishes this by sustaining a higher level of homeostatic proliferation of recirculating 
memory CD8 T cells than do spleen and lymph nodes (LN) in the steady state. This slow intermittent 
cell division would counteract cell death, thus contributing to the stable maintenance of memory 
T cell numbers over time. In a recent article entitled “Memory CD8+ T cells colocalize with IL-7+ 
stromal cells in bone marrow and rest in terms of proliferation and transcription,” Sercan Alp and 
coworkers challenge this view (2). They emphasize that results on memory CD8 T cell proliferation 
are discrepant and propose that the BM instead provides survival signals for resident memory CD8 
T cells, as it does for plasma cells (3–5). They show that BM memory CD8 T cells colocalize with 
stromal cells, expressing the prosurvival cytokine IL-7. Moreover, they demonstrate that CD69, i.e., a 
typical marker of tissue-resident memory T cells, is expressed by a higher proportion of memory CD8 
T cells in the BM than in the spleen. Finally, they show that freshly isolated BM memory CD8 T cells 
have a predominant resting transcriptional profile, in comparison with in vitro-activated CD8 T cells (2).
Starting from the article by Sercan Alp et al., this commentary revisits the data published so far 
on memory CD8 T cell proliferation in the BM and suggests that apparent discrepancies can be 
reconciled by a detailed analysis (see Table 1 and references therein). In respect to the interplay 
between memory CD8 T cells and other cells within BM niches and the possibility that BM memory 
T cells represent a pool of tissue-resident memory T cells, the reader is referred to another article 
in this issue (6).
Sercan Alp and coworkers examined memory CD8 T cell proliferation or quiescence in mice 
by three methods, i.e., DNA content analysis, bromodeoxyuridine (BrdU) incorporation, and Ki67 
staining (2).
DNA content analysis measures the percentage of cells in S/G2/M phase of cell cycle at a given 
time, thus providing a static index of proliferation in untreated individuals (16). By this method, 
Sercan Alp et  al. found that the frequency of dividing cells within memory-phenotype CD44high 
taBle 1 | Summary of published results on total CD8 and memory CD8 t cell proliferation in bone marrow, grouped according to experimental 
methods.
CD8 t cells Bm lymphoid periphery/blood reference
(a) Dna content
Species
Mouse CD8+ ↑ Spleen and PLN Parretta et al. (7)
Mouse CD8+ Ag-specific P14 (LCMV) ↑ Spleen, total LN, and blood Becker et al. (8)
Mouse CD8+ CD44hi ↑ Spleen Sercan Alp et al. (2)
Human CD8+ CD45RA− CD45R0+ ↑ Blood Okhrimenko et al. (9)
(B) BrdU
BrdU administration
1 i.v. injection, 1 h before analysis CD8+ ↑ Spleen, PLN, MLN, CLN, and blood Westermann et al. (10)
In drinking water for 3 d CD8+ ↑ Spleen, PLN, and MLN Parretta et al. (7)
CD8+ CD44hi ↑ Spleen, PLN, and MLN
CD8+ Ag-specific (OVA) ↑ Spleen and PLN
CD8+ Ag-specific OT-I (OVA) ↑ Spleen and PLN
1 i.v. injection, 1 d before analysis CD8+ CD44hi ↑ Spleen Becker et al. (8)
CD8+ Ag-specific P14 (LCMV) ↑ Spleen, total LN, and blood
In drinking water for 3 d CD8+ CD122hi ↑ Spleen, PLN, and MLN Cassese et al. (11)
In drinking water for 3 d (tx mice) CD8+ ↑ Spleen and PLN Parretta et al. (12)
In drinking water for either 14 or 42 d (tx mice) CD8+ CD44hi ↑ Spleen and PLN Parretta et al. (12)
In drinking water for either 5 or 8 d CD8+ ↑ Spleen Snell et al. (13)
In drinking water with sugar for 3 d CD8+ CD44hi ↑a Spleen Sercan Alp et al. (2)
(C) CFSe
CFSe-labeled cell transfer
Splenocyte transfer, either 15 or 25 d before analysis CD8+ CD44hi ↑ Spleen, total LN, and blood Becker et al. (8)
CD8+ Ag-specific P14 (LCMV) ↑ Spleen, total LN, and blood
Splenic CD8+ CD44hi cell transfer, 7 d before analysis CD8+ CD44hi ↑ Spleen and PLN Quinci et al. (14)
In vitro primed OT-I splenocyte transfer, 21 d before 
analysis
CD8+ Ag-specific OT-I (OVA) ↑ Spleen and PLN Lin et al. (15)
The table summarizes published proliferation results on total CD8 and memory CD8 T cells in BM, in comparison with corresponding cells from lymphoid periphery/blood.  
The arrow ↑ indicates that results in BM were higher than those in lymphoid periphery/blood. Lymphoid periphery comprised spleen and LN, as indicated. Please, note that in all 
reports, spleen, LN, and blood were all concordantly lower than the BM. All results were obtained by flow cytometry, except for Westermann et al. (10), in which cell suspension 
analysis was performed by microscopy. (A) DNA content results are expressed as percentages of cells having 2n < DNA ≤ 4n; (B) BrdU results are expressed as percentages of 
BrdU+ cells after a BrdU pulse or BrdU continuous labeling in drinking water, as indicated; and (C) CFSE results are expressed as percentages of donor CFSE+ cells with decreased 
CFSE staining intensity, after CFSE-labeled cell transfer, as indicated. All BrdU and CFSE experiments were performed in mice, except for experiments by Westermann et al. (10), 
which were performed in rats.
Ag, antigen; BM, bone marrow; BrdU, bromodeoxyuridine; CFSE, carboxyfluorescein diacetate succinimidyl ester; CLN, cervical lymph nodes; d, day; h, hour; i.v., intravenous; 
LCMV, lymphochoriomeningitis virus; LN, lymph nodes; MLN, mesenteric lymph nodes; OT-I, TCR transgenic cells expressing a TCR against OVA; OVA, ovalbumin; PLN, peripheral 
lymph nodes; P14, TCR transgenic cells expressing a TCR against LCMV; Ref., reference; tx, thymectomized.
aIndicates that an abnormal proliferation was observed upon BrdU treatment (see text for details).
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CD8 T cells in the BM was only about 0.4%. However, this low 
percentage was still three to eight times higher than that found in 
corresponding spleen samples [(2), BM 0.32–0.47% and spleen 
0.05–0.10%; see Figures 4E and S3], in line with what has been 
seen in other studies by comparing CD8 T cells from BM with 
those from blood, spleen, or LN (7–9).
Sercan Alp et al. showed that assessment of CD8 T cell prolif-
eration by BrdU incorporation may be misleading (2). BrdU is a 
thymidine analog that labels cells during S phase, thus marking 
the cells undergoing division in the course of BrdU treatment. 
Depending on dose and length of treatment, BrdU may have toxic 
effects, potentially leading to artifacts (17). In mice, BrdU is either 
injected or administered in drinking water, sometimes with sugar 
addition, a stratagem used to overcome the unpleasant taste of 
the analog (18, 19). Sugar can increase water consumption, e.g. 
in 4 hours mice drink 0.5–1.5 ml tap water and 2–4 times more 
water containing 10% sugar (20). However, total water intake is 
not usually measured in BrdU experiments, leaving actual BrdU 
dose undetermined. In the study by Sercan Alp et al., the mice 
were treated with 1  mg/ml BrdU plus 10% sugar in drinking 
water for 3 days, and there was an artificial rise – especially in 
the BM – of dividing memory CD8 T cell frequency, as measured 
by a BrdU-independent method [(2), Figure 4E]. Based on these 
results, the authors suggest that previous studies had greatly 
overestimated the extent of memory CD8 T cell proliferation (2).
However, other authors have used lower doses of BrdU with-
out sugar (7, 12, 21–23), and Parretta et al. found little difference 
in proliferation (when tested by a BrdU-independent assay) 
between mice treated with BrdU or not (12). In more details, to 
compare the two groups of mice, Parretta et al. measured CD8 
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T cell proliferation by carboxyfluorescein diacetate succinimidyl 
ester (CFSE), a cytoplasmic dye that is equally distributed between 
daughter cells upon division. They reported that the proportion 
of dividing (i.e., CFSElow) CD8 T cells in spleen, LN, and BM in 
response to PolyI:C injection was similar when mice were either 
untreated or treated with 0.8 mg/ml BrdU in drinking water for 
3  days (12), a standard protocol (24). PolyI:C treatment might 
have masked the toxic effects of BrdU (12); nevertheless, the dose 
of BrdU plus sugar is a major difference between the Sercan Alp 
et al.’s study and those of other groups. Indeed, the percentage 
of BrdU+ cells within spleen CD44high CD8 T cells reported by 
Sercan Alp et al., i.e., about 30%, was definitely higher in compari-
son with previous data reported by several authors, all obtained 
with 0.8 mg/ml BrdU in drinking water for 3 days and no sugar 
(7, 21, 23). For example, Parretta et al. found that the fraction of 
BrdU+ cells within CD44high CD8 T cells was 6% in spleen, 5% 
in LN, and 13% in BM, on average (7). Taking everything into 
account, it could be argued that the confounding effect of BrdU 
on BM CD8 T cell proliferation was dose dependent and limited 
to the study by Sercan Alp and coworkers (2).
Finally, Sercan Alp et  al. analyzed CD8 T cells by intracel-
lular staining for Ki67, a cell-cycle marker. They showed that 
on average, 93–95% of the memory CD8 T cells are negative 
for Ki67 (i.e., in G0 phase) in the BM and 88–94% in the spleen 
[(2), Figures 4B,D]. This indicates that the vast majority of the 
cells are quiescent and non-dividing at a given time, with a slight 
difference between BM and spleen. However, it should not be 
overlooked that the Ki67 assay does not give any information on 
frequency of dividing cells (i.e., in S/G2/M), since all cells in G1/S/
G2/M score positively for Ki67. It appears that rather than being in 
contrast with previous findings on proliferation obtained by other 
methods (see Table 1 and references therein), the Ki67 results in 
the Sercan Alp et al.’s study simply report on a different aspect of 
the cell cycle.
Table 1 is a summary of published findings on total CD8 and 
memory CD8 T cell proliferation in BM, grouped according 
to the experimental methods. In addition to DNA content and 
BrdU, some authors used CFSE. For example, Quinci et al. found 
that in 1 week the fraction of CFSElow cells within CD44high CD8 
T cells was 17% in spleen, 17% in LN, and 27% in BM, on average 
(14). All data in Table 1 show a higher percentage of proliferating 
cells within memory CD8 T cells in the BM than in lymphoid 
periphery, i.e., spleen, LN, and blood.
Thus, the data on proliferation are in agreement, while 
discrepancies remain in interpretations (25, 26). The main 
point of contention is how much the proliferation occurring in 
the BM contributes to the long-term maintenance of memory 
CD8 T cells. Sercan Alp et  al. focused their attention on the 
paucity of proliferating cells in their BM samples (2), ignor-
ing that this is, nevertheless, a higher proportion than that 
found in spleen and LN. It could be argued that such differ-
ence in proliferating cell frequencies should not be neglected, 
in light of the fact that BM memory CD8 T cells are a large 
population. Indeed, the BM is a huge organ and, moreover, 
after the peak of an acute response, antigen-specific CD8 
T cell contraction is often less pronounced in the BM than 
in other organs, resulting in a high number of memory CD8 
T cells in the BM in the memory phase (7, 8, 27, 28). For example, 
in the contraction phase of the response against the M-45 epitope 
of murine cytomegalovirus (MCMV), the frequency of antigen-
specific CD8 T cells dropped 14–20 times in the blood, liver, and 
lung, and only about five times in the BM (28). Moreover, at late 
times (6–10 weeks) after immunization against the model anti-
gen ovalbumin, the number of antigen-specific memory CD8 T 
cells in the BM was 2–3 times higher than that in the spleen and 
3–11 times higher than that in total LN (7). However, enrich-
ment of antigen-specific CD8 T cells in the BM in the memory 
phase was not observed in other types of responses. For example, 
at late times after infection, antigen-specific memory CD8 T cell 
frequency in the BM was not higher than that in blood, liver, or 
lung in the inflationary response against the M-38 epitope of 
MCMV (28) or in the response against vaccinia virus induced by 
skin scarification, which mostly elicited antigen-specific tissue-
resident memory CD8 T cells in the skin (29).
Taking everything into account, the BM plays a preferential 
role in sustaining the homeostatic proliferation of antigen-specific 
memory CD8 T cells following classical acute responses resulting 
in the long-term systemic memory (1, 7, 8, 30).
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